“At Harmony, we put breakthrough science within reach, and take seriously our commitments to those who live with rare diseases, our employees, business partners and the broader life sciences community.”
John Jacobs, Chief Executive Officer
Harmony Biosciences is an innovative biopharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare, orphan diseases. With a focus on central nervous system disorders, our goal is to push the boundaries of what science can do to improve the lives of those whose medical conditions could benefit from the potential of first-in-class, mechanism-based treatment approaches.
“We believe it takes both scientific vision and tenacity to pursue new therapies that will have the potential to transform the lives of patients.”
Jeffrey Dayno, M.D., Chief Medical Officer